Immix Biopharma (IMMX) Earnings Date & Reports

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

IMMX is expected to report earnings to fall 8.00% to -23 cents per share on May 28

Immix Biopharma IMMX Stock Earnings Reports

Q1'25

Est.

$-0.23

Q4'24

Est.

$-0.25

Q3'24

Missed

by $0.08

Q2'24

Est.

$-0.15

Q1'24

Est.

$-0.23

The last earnings report on February 26 showed earnings per share of -25 cents, meeting the estimate of -25 cents. With 29.18K shares outstanding, the current market capitalization sits at 40.56M.

View a ticker or compare two or three

Compare

IMMX